Search by Drug Name or NDC

NDC 51655-0776-52 benzonatate 200 mg/1 Details

benzonatate 200 mg/1

benzonatate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals. The primary component is BENZONATATE.

MedlinePlus Drug Summary

Benzonatate is used to relieve cough. Benzonatate is in a class of medications called antitussives (cough suppressants). It works by reducing the cough reflex in the lungs and air passages.

Related Packages: 51655-0776-52
Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Benzonatate

Product Information

NDC	51655-0776
Product ID	51655-776_da807eb3-349f-61b9-e053-2995a90a0e21
Associated GPIs	43102010000110
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	benzonatate
Proprietary Name Suffix	n/a
Non-Proprietary Name	benzonatate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	200
Active Ingredient Units	mg/1
Substance Name	BENZONATATE
Labeler Name	Northwind Pharmaceuticals
Pharmaceutical Class	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA040749
Listing Certified Through	2024-12-31

Package

NDC 51655-0776-52 (51655077652)

Pricing Information	N/A
NDC Package Code	51655-776-52
Billing NDC	51655077652
Package	30 CAPSULE in 1 BOTTLE, PLASTIC (51655-776-52)
Marketing Start Date	2021-07-09
NDC Exclude Flag	N